ZIOP..$4.60 says it will announce topline results phase 3 Palifosfamide last week of March. Definitely a trader's play. On watch here.
Message in reply to: ZIOP Phase 3 Trial of Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Events
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.